Elixir Life Care

Pharmaceutical manufacturing and distribution services in India.

About Elixir Life Care

Elixir Life Care is a Healthcare company. It operates as a pharmaceutical manufacturing and distribution services in India. The company has 23 employees. Its Indian entity Elixir Life Care Private Limited reported revenue of β‚Ή35.03 Cr. Elixir Life Care offers products and services including Soft Gelatin Capsules and Tablets. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Drug Production and Consumer Goods.

Company details

Elixir Life Care is recognized as a pharmaceutical company that focuses on advancing medical science through ethical practices and high standards of quality and safety. Products such as soft gelatin capsules, tablets, and ayurvedic items are developed to support patient well-being, with an emphasis on contract manufacturing and branding. The company is noted for its ISO certification, dedicated workforce, and compliance with industry norms, ensuring reliable delivery of medicines across various categories. Integrity and accountability are maintained in all operations, contributing to its reputation in the market.

  • Employees 23
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Legal Name Elixir Life Care Pvt Ltd
  • Date of Incorporation 04 Feb, 2009
  • Jurisdiction Chennai, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹35.03 Cr

    FY 2025 · -1% YoY

  • Net Profit
    ₹26.9 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹1.70 Cr

    FY 2025 · 5% margin

  • Employee Count
    23

Products & Services of Elixir Life Care

Elixir Life Care offers a comprehensive portfolio of products and services, including Soft Gelatin Capsules and Tablets.

Soft Gelatin Capsules
Pharmaceutical Products

Soft gelatin capsules are manufactured and supplied for various health applications, focusing on quality and safety standards

Tablets
Pharmaceutical Products

Tablets are produced in a range of formulations to address medical needs, adhering to established quality norms

Board of directors of Elixir Life Care Private Limited (Elixir Life Care)

Elixir Life Care Private Limited is the primary company behind Elixir Life Care. The board of Elixir Life Care Private Limited currently have 5 directors; the longest-serving is Sanjay Kumar Ashok Shah, appointed in 2009. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sanjay Kumar Ashok Shah
DIN 02575025
Director25 Feb 200917 yrs 7 moElixir Life Care Private Limited
Kamlesh Modi
DIN 02575038
Director10 Mar 201511 yrs 7 moElixir Life Care Private Limited
Ranjith Kumar Madanchand
DIN 02500680
Director10 Mar 201511 yrs 7 moElixir Life Care Private Limited
Narendar Singh Guleria
DIN 07139317
Director28 Mar 201511 yrs 6 moElixir Life Care Private Limited
Dhandeep Meethalal
DIN 02588634
Director29 May 20251 yr 4 moElixir Life Care Private Limited

Financials of Elixir Life Care

Figures of Elixir Life Care Private Limited, the primary company behind Elixir Life Care, for FY 2025. Revenue was ₹35.03 Cr (-1% year on year). Net profit was ₹26.9 Lakh (1% margin). EBITDA was ₹1.70 Cr (5% margin). Revenue has grown at a compounded annual rate of +12% over three years and +12% over five years.

  • ₹35.03 CrRevenue · FY 2025 · -1% YoY
  • ₹26.9 LakhNet profit · 1% margin
  • ₹1.70 CrEBITDA · 5% margin
  • ₹10 LakhPaid-up capital
  • 23Employees (provident fund records)
  • +12%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Elixir Life Care Private Limited are on its company page.

Premium access

Detailed financial statements for Elixir Life Care

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Elixir Life Care (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Elixir Life Care

Elixir Life Care has 23 employees.

The primary company behind Elixir Life Care, Elixir Life Care Private Limited, reported revenue of β‚Ή35.03 Cr for FY 2025, down 1% year on year.

Elixir Life Care is recognized as a pharmaceutical company that focuses on advancing medical science through ethical practices and high standards of quality and safety. Products such as soft gelatin capsules, tablets, and ayurvedic items are developed to support patient well-being, with an emphasis on contract manufacturing and branding. The company is noted for its ISO certification, dedicated workforce, and compliance with industry norms, ensuring reliable delivery of medicines across various categories. Integrity and accountability are maintained in all operations, contributing to its reputation in the market.

Elixir Life Care offers Soft Gelatin Capsules and Tablets.

Elixir Life Care operates through Elixir Life Care Private Limited.

The legal entities of Elixir Life Care currently have 5 directors, including Narendar Singh Guleria, Kamlesh Modi, Dhandeep Meethalal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available